New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
14:02 EDTHUM, AMEDAmedisys sinks after warning new deal will generate less revenue
Home health care provider Amedisys (AMED) is tumbling after the company renewed its contract with health insurer Humana (HUM), but predicted that the new deal would generate 50% less revenue than the previous agreement. The new contract may cover fewer markets and Amedisys will be paid on a per visit basis, rather than on an episodic basis as was previously the case, Amedisys reported. Amedisys, which noted that it had previously generated $65M-$70M in revenue from Humana each year, said the new agreement would begin impacting its revenue this quarter. However, the "full impact" of the deal won't be felt until 2013, the home health care provider added. In mid-afternoon trading, Amedisys sank $1.39, or 10.43%, to $11.94.
News For AMED;HUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 28, 2015
17:21 EDTAMEDAmedisys receives Subpoena Duces Tecum issued by DoJ
Amedisys announced that, on May 21, it received a Subpoena Duces Tecum issued by the U.S. Department of Justice. The Subpoena requests the delivery of information regarding 53 identified hospice patients to the United States Attorney’s Office for the District of Massachusetts. It also requests the delivery of documents relating to the Company’s hospice clinical and business operations and related compliance activities. The Subpoena generally covers the period from January 1, 2011, through the present. The Company is fully cooperating with the U.S. Department of Justice with respect to this investigation. No assurance can be given as to the timing or outcome of this investigation.
May 27, 2015
10:01 EDTAMEDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:11 EDTAMEDAmedisys upgraded to Buy on industry and company tailwinds at SunTrust
As previously reported, SunTrust upgraded Amedisys to Buy from Neutral and increased its price target to $36 from $31. The firm believes the home health sector is extremely well positioned and applauds Amedisys' recent decision to abandon its AMS3 system and transition to Homecare Homebase. SunTrust said the transition will ultimately decrease both capex and IT spend and improve clinician capacity. In addition, the firm's analyst said Amedisys has added management talent and views the strong balance sheet and robust free cash flow as unappreciated.
06:49 EDTAMEDAmedisys upgraded to Buy from Neutral at SunTrust
Subscribe for More Information
May 19, 2015
12:04 EDTHUMAnthem CFO says 'good time' for 'meaningful' acquisition, Reuters reports
Subscribe for More Information
06:21 EDTAMEDAmedisys management to meet with SunTrust
Meeting to be held in Boston on May 20 hosted by SunTrust.
May 15, 2015
11:08 EDTHUMOmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use